...Renxi Li; Shawn Sarin Background: Transjugular intrahepatic portosystemic shunt (TIPS) is a procedure to alleviate portal hypertension in patients with decompensated liver cirrhosis. While prior research highlighted racial disparities in TIPS, Asian Americans were not included in the investigation...

...Tim R. Glowka; Jörg C. Kalff; Steffen Manekeller Background: Bleeding from esophagogastric varices is a life-threatening complication from portal hypertension. It occurs in 15% of patients and has a mortality rate of 20–35%. Summary: The primary therapy for variceal bleeding is medical. In cases...

..., instructions or products referred to in the content or advertisements. Acute liver failure Anticoagulation Bleeding Cirrhosis Portal hypertension Alterations in hemostasis are a characteristic feature of advanced liver disease [ 1,2,3 ]. Traditionally, impaired protein synthesis (affecting...

...Jonel Trebicka; Thomas Reiberger; Wim Laleman Summary Acute-on-chronic liver failure (ACLF) is considered a distinct syndrome in patients with liver disease, with systemic inflammation playing a central role. Portal hypertension (PHT) is also aggravated by inflammation and may subsequently impact...

...Tim R. Glowka; Jörg C. Kalff; Nico Schäfer Background: Bleeding from esophageal varices is a life-threatening complication of chronic portal hypertension (PH), occuring in 15% of patients with a mortality rate between 20 and 35%. Methods: Based on a literature review and personal experience...

... with liver cirrhosis should be screened for portal hypertension before anticoagulation is mandatory. Therapy of chronic PVT is discussed controversially; therefore, a strict patient selection and an individual therapeutic decision are warranted depending on the etiology of PVT. Special forms of PVT including...